Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Recruiting

Phase 3

Observational StudyImpact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Sponsor:

NRG Oncology

Code:

NCT05646316

Conditions

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Diagnostic Imaging Testing

Excisional Biopsy

Indocyanine Green Solution

Minimally Invasive Surgery

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by NRG Oncology on 2025-05-25.